These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 18022078)
21. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation. Reid DW; Walters EH; Johns DP; Ward C; Burns GP; Liakakos P; Williams TJ; Snell GI J Heart Lung Transplant; 2005 Apr; 24(4):489-92. PubMed ID: 15797754 [TBL] [Abstract][Full Text] [Related]
22. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation. Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692 [TBL] [Abstract][Full Text] [Related]
23. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome. Shitrit D; Amital A; Fox B; Kramer MR Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973 [TBL] [Abstract][Full Text] [Related]
24. Successful bilateral lung transplant outcomes in recipients 61 years of age and older. Palmer SM; Davis RD; Simsir SA; Lin SS; Hartwig M; Reidy MF; Steele MP; Eu PC; Blumenthal JA; Babyak MA Transplantation; 2006 Mar; 81(6):862-5. PubMed ID: 16570009 [TBL] [Abstract][Full Text] [Related]
25. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. Ross DJ; Marchevsky A; Kramer M; Kass RM J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775 [TBL] [Abstract][Full Text] [Related]
26. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. Dusmet M; Maurer J; Winton T; Kesten S J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991 [TBL] [Abstract][Full Text] [Related]
27. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913 [TBL] [Abstract][Full Text] [Related]
28. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741 [TBL] [Abstract][Full Text] [Related]
29. Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205 [TBL] [Abstract][Full Text] [Related]
30. Early changes in basement membrane thickness in airway walls post-lung transplantation. Law L; Zheng L; Orsida B; Levvey B; Oto T; Kotsimbos AT; Snell GI; Williams TJ J Heart Lung Transplant; 2005 Oct; 24(10):1571-6. PubMed ID: 16210132 [TBL] [Abstract][Full Text] [Related]
31. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. Kesten S; Chaparro C; Scavuzzo M; Gutierrez C J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139 [TBL] [Abstract][Full Text] [Related]
32. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129 [TBL] [Abstract][Full Text] [Related]
33. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome. Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206 [TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808 [TBL] [Abstract][Full Text] [Related]
35. Long-term clarithromycin therapy in the management of lung transplant recipients. Benden C; Boehler A Transplantation; 2009 May; 87(10):1538-40. PubMed ID: 19461491 [TBL] [Abstract][Full Text] [Related]
36. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787 [TBL] [Abstract][Full Text] [Related]
37. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476 [TBL] [Abstract][Full Text] [Related]
38. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems. Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111 [TBL] [Abstract][Full Text] [Related]